LORZIDE

This brand name is authorized in Nigeria.

Active ingredients

The drug LORZIDE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 3ST302B24A - LOSARTAN POTASSIUM
 

Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.
 
Read more about Losartan
2
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
 

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
 
Read more about Hydrochlorothiazide

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-7995 Tablet Lorzide Tablet TAB 50 mg; 12.5 mg 3 x 10's (in Alu-Alu blisters) Film Coated Tablet 34 RNW-PP-338671 LORZIDE TABLET LOSARTAN POTASSIUM USP 50MG & HYDROCHLOROTHIAIDE USP 12.5MG LOSARTAN POTASSIUM USP 50MG & HYDROCHLOROTHIAIDE USP 12.5MG excipients: microcrystalline cellulose BP 36.5MG, lactose monohydrate BP 39.05MG, Maize Starch Bp 27.75, hydroxy propyl cellulose bp 03.8mg, isopropyl alcohol (IPA) 82.40MG, AC Di sol IH 07.60mg,collodial anhydrous silica BP 00.95MG, SODIUM LAURYL SULPHATE BP 02.00MG, PURIFIED TALE BP 01.90MG, MAGNESIUM STEARATE BP01.90 B4-7995 Drugs Imported Products 3x10Tablet POM 1 7/5/2023 UNOSOURCE PHARMA NIGERIA LIMITED, 47, Babaponmile Street, Onipetesi-Mongoro 234803854 unosourcepharmangltd@yahoo.com AKUMS DRUGS & PHARMACEUTICALS LIMITED, 19, 20, 21, SECTOR-6A, I.I.E., SIDCUL, RANIPUR, HARIDWAR-249403, INDIA., India 31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09DA01 Losartan and diuretics C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-7995

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈